However, the cell line models (MCF-7, T47D and ZR-75-1) and limited numbers of patient-derived ER + BC organoids (two) utilised in this study may not capture the full spectrum of the complexity and interpatient heterogeneity of the ER + breast cancers. This evidence concerns the gene ESR1 and breast carcinoma.